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5’AMP-activated protein kinase (AMPK) is considered to have a role in regulating 
skeletal muscle mass. However, there are no studies investigating the function of AMPK 
in modulating skeletal muscle mass during atrophic conditions. In the present study, we 
investigated the difference in unloading-associated muscle atrophy and molecular 
functions in response to 2-week hindlimb suspension between transgenic mice 
overexpress dominant-negative mutant of AMPK (AMPK-DN) and their wild-type 
littermates (WT) mice. Male WT (n=24) and AMPK-DN (n=24) mice were randomly 
divided into two groups: untreated preexperimental control (n=12 in each group) and 
unloading (n=12 in each group) groups. The relative soleus muscle weight and fiber cross-
sectional area to body weight were decreased by ~30% in WT mice by hindlimb 
unloading, while by ~20% in AMPK-DN mice. There were no changes in the indicators 
of protein synthesis: puromycin-labeled rotein and Akt/70-kDa ribosomal S6 kinase 
signaling. The expressions of ubiquitinated proteins and muscle RING finger 1 mRNA 
and protein, markers of ubiquitin-proteasome system, were increased by hindlimb 
unloading in WT mice but not in AMPK-DN mice. The expressions of molecules related 
to protein degradation system, phosphorylated forkhead box class O 3a, inhibitor of κBα, 
microRNA (miR)-1 and miR-23a were decreased in only WT mice in response to 
hindlimb unloading, and 72-kDa heat shock protein expression was higher in AMPK-DN 
mice than WT mice. These results imply that AMPK partially regulates unloading-
induced atrophy of slow-twitch muscle possibly through modulating protein degradation 











Skeletal muscle is the largest tissue in the body, accounting for approximately 40% 
of the total body mass, and has a crucial role in metabolism as well as locomotion. 
Skeletal muscle has a high ability to adapt to multiple stimuli. Increased loading such as 
resistance training and mechanical stretching leads to skeletal muscle hypertrophy (18, 
75). In contrast, aging, poor nutrition, several diseases such as diabetes, cancer, sepsis, 
and chronic renal failure, and decreased loading such as inactivity, lead to skeletal muscle 
atrophy (23, 34, 39). Skeletal muscle atrophy occurs by the result of changes in protein 
turnover; decreased protein synthesis, increased protein degradation, or combination of 
both (17). The coordination of protein turnover in atrophic process is regulated by 
complicated molecular responses and the molecular mechanism involved in this process 
in skeletal muscle is yet completely understood and remains to be elucidated. 
5’AMP-activated protein kinase (AMPK) is well established as a metabolic sensor 
that helps maintain cellular energy homeostasis by modulating glucose, lipid, and protein 
metabolism (16, 26, 28). AMPK is a heterotrimeric kinase comprising a catalytic α 
subunit and two regulatory subunits, β and γ. Two distinct α-isoforms (α1 and α2) are 
exist in mammalian cells: α1 is expressed ubiquitously, whereas α2 is dominant in skeletal 
muscle, heart, and liver (69). Binding of AMP to a Bateman domain of the γ-subunit of 
AMPK induces the allosteric activation of AMPK and phosphorylation of the Thr172 
residue of the α-subunit, which is essential for full kinase activity (27, 59). 
Several studies in the past decade suggest that AMPK has a potential role in 
regulating skeletal muscle mass. Gordon et al. (21, 72) provided the evidence that 
elevated AMPK activity was associated with diminished capacity for hypertrophy of fast-
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twitch skeletal muscle in aged rat. Moreover, Paturi et al. (55) suggested that impaired 
hypertrophy of slow-twitch skeletal muscle during overload in diabetic rat was partly 
attributed to increased AMPK phosphorylation. A recent study using a knockout mouse 
model demonstrated that overload-induced muscle hypertrophy was accelerated in 
AMPKα1-deficient mice compared to the wild-type mice (50). Correspondingly, we (13) 
showed in vitro that stimulation with a pharmacological AMPK agonist on cultured 
skeletal muscle cells inhibited myotube hypertrophy and this response was attenuated in 
the AMPKα1/α2-knockdown condition. In addition, skeletal muscle-specific 
AMPKα1/α2 double knockout mice exhibit higher muscle mass than the wild-type mice 
in normal growth condition (37, 38). Taken together, it is suggested that AMPK is 
involved in the modulation of skeletal muscle mass during hypertrophic and growth 
conditions. 
Recently, it was shown that AMPK pathway was activated in atrophic gastrocnemius 
muscle of mice at the early stage (3 days) of hindlimb unloading (11). However, it was 
not revealed whether the increase of AMPK by hindlimb unloading was directly 
associated with the progress of muscle atrophy. Therefore, we firstly aimed to evaluate 
the potential function of AMPK in skeletal muscle atrophy in response to hindlimb 
unloading. 
AMPK is known to modify several signaling molecules that engage protein synthesis 
and degradation. It is accepted that AMPK inhibits mTOR signaling pathway (5), which 
is the major signaling pathway regulating protein synthesis. Indeed, the interaction of 
AMPK and mTOR signaling in regulating muscle hypertrophy was reported previously 
(50). On the other hand, AMPK seems to control protein degradation via two major 
catabolic systems in skeletal muscle; ubiquitin-proteasome (35, 52) and autophagy 
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systems (62) are activated by pharmacological AMPK stimulation. We (13) also 
demonstrated previously that AMPK inhibits hypertrophy partly through 72-kDa heat 
shock protein (HSP72)-mediated activation of ubiquitin-proteasome system in skeletal 
muscle cells. In addition, our data in the study suggested that a post-transcriptional 
regulation by microRNA (miRNA) might be associated with the activating process of 
ubiquitin-proteasome system. The discovery of miRNAs has provided a new aspect that 
could expand our knowledge to understand mechanisms of skeletal muscle atrophy (68, 
77). Therefore, we secondly aimed to evaluate the possible involvement of these 
molecules in AMPK-mediated regulation of muscle mass during hindlimb unloading.  
For these purpose, we examined the alterations of muscle mass and molecular 
responses after 2-week hindlimb unloading using transgenic mice that overexpress 
muscle-specific dominant-negative mutant of AMPKα1 (AMPK-DN) (44). AMPK-DN 
mice exhibit almost complete depletion in AMPKα2 activity and moderate depletion in 
AMPKα1 activity (15, 32, 44, 70). We found that loss of muscle mass in slow-twitch 
soleus muscle, but not fast-twitch gastrocnemius-plantaris complex and EDL muscles, of 
AMPK-DN mice during hindlimb unloading was less than that of wild-type littermates 
(WT) mice. Furthermore, we found that the adaptive responses of the molecules related 
to protein degradation during hindlimb unloading were attenuated in atrophic soleus 
muscle of AMPK-DN mice compared to WT mice. Our findings give new insights into 





MATERIALS AND METHODS 
 
Animals 
Transgenic (AMPK-DN) mice expressing a dominant negative mutant of AMPKα1 
in the skeletal muscle (44) were obtained from JCRB (Japanese Collection of Research 
Bioresources Cell Bank) Laboratory Animal Resource Bank at NIBIO (National Institute 
of Biomedical Innovation, Osaka, Japan). This strain expresses transgene introduced 
D157A mutation into cDNA encoding full length amino acid sequence of rat AMPK α1 
subunit under the control of human α actin promoter on -2,000 bp. The heterozygous 
AMPK-DN mice were backcrossed with C57BL/6NCr mice, and twenty-four male 
AMPK-DN mice (age: 13.2 ± 3.2 weeks, body weight: 24.4 ± 1.5 g, mean ± SD) and 
twenty-four their WT mice (age: 13.5 ± 3.5 weeks, body weight: 23.2 ± 2.9 g, mean ± 
SD) were used. All mice were housed in an animal room maintained at 22-24°C with a 
12:12-h light-dark cycle and fed a standard laboratory diet and water ad libitum. All 
animal protocols were carried out in accordance with the Guide for the Care and Use of 
Laboratory Animals as adopted and promulgated by the National Institutes of Health 
(Bethesda, MD) and were approved by the Animal Use Committee at Toyohashi SOZO 
University (A2012001, A2013003, A2014003). All treatments of animals were 
performed under anesthesia with intraperitoneal injection of sodium pentobarbital (50 
mg/kg), and all efforts were made to prevent discomfort and suffering. 
 
Procedure of hindlimb unloading 
Both AMPK-DN and WT mice were randomly divided into two groups: untreated 
preexperimental control (n=12 in each group) and unloading (n=12 in each group) groups. 
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Mice of the unloading group were subjected to continuous hindlimb suspension for 2 
weeks. Hindlimb suspension was performed as described previously (43). Briefly, tails of 
the mice were cleaned, and were loosely surrounded by adhesive tapes cross-sectionally, 
fixing a string on the dorsal side of the tail, to keep the blood flow intact. The string was 
fastened to the roof of the cage at a height allowing the forelimbs to support the weight, 
yet preventing the hindlimbs from touching the floor and the sides of the cage. The mice 
could reach food and water freely by using their forelimbs. Body weight of each mice 
was recorded at the end of experiment.  
 
Protein synthesis measurements 
Protein synthesis was measured by the surface sensing of translation (SUnSET) 
method as previously described (20). Briefly, 30 min before tissue collection, some mice 
(n=4 in each group) were injected intraperitoneally with puromycin (0.04 μmol/g) 
dissolved in 100 μl of phosphate buffered saline (PBS) under anesthesia. The expression 
of puromycin-labled proteins was analyzed by Western blot analyses as described below.  
 
Tissue collection 
Under anesthesia, soleus, extensor digitorum longus (EDL), and gastrocnemius-
plantaris complex (GAS-PLA) muscles were dissected from each mice and weighed. We 
analyzed each molecule in each soleus muscle dissected from each mouse. Briefly, left 
soleus muscle were cross-sectionally cut into halves at the midbelly region, and proximal 
half of the left muscles were immediately frozen in 2-methylbutane cooled with liquid 
nitrogen and stored at -80°C for muscle fiber cross-sectional area (fiber CSA) analyses. 
Distal half of the left muscles for real-time RT-PCR analyses and right muscles for 
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western blot analyses and AMPK kinase assay were frozen in liquid nitrogen, and stored 
at -80°C.  
 
Western blot analyses 
Sample preparation and western blot analyses were performed with some 
modification of the previously reported method (14, 53). Briefly, the soleus muscles (>4 
mg) were homogenized in 60 times its weight of ice-cold lysis buffer (CelLytic MT, 
Sigma-Aldrich, St. Louis, MO) with Protease/Phosphatase Inhibitor Cocktail (5872, Cell 
Signaling Technology, Danvers, MA) that contains inhibitors against the major classes of 
endogenous proteases and phosphatases. The homogenates were then sonicated and 
centrifuged at 16,000 g at 4°C for 15 min. The supernatants were collected for the 
determination of protein contents by using the Bradford technique. Protein contents in the 
supernatants were >420 μg in each muscle. The supernatants were solubilized in 
Laemmli’s sample buffer containing mercaptoethanol and boiled. Samples (10 μg of 
protein) were separated by SDS-PAGE using a 7.5, 10, or 12% polyacrylamide gel. 
Proteins were then transferred to polyvinylidene difluoride membranes by using Trans-
Blot Turbo transfer system (Bio-Rad Laboratories. Hercules, CA). Membranes were 
blocked for 1 h at room temperature in Blocking One-P (Nacalai Tesque, Kyoto, Japan) 
and then incubated overnight at 4°C with primary antibodies [acetyl-CoA carboxylase 
(ACC) Ser79 (3661, Cell Signaling Technology, Danvers, MA), ACC (3662, Cell 
Signaling Technology), Akt Ser473 (9271, Cell Signaling Technology), Akt (9272, Cell 
Signaling Technology), forkhead-box class O (FoxO) 3a Ser253 (9466, Cell Signaling 
Technology), FoxO3a (2497, Cell Signaling Technology), HSP72 (ADI-SPA-812, Enzo 
Life Sciences, Farmingdale, NY), heat shock transcription factor 1 (HSF1) (4356, Cell 
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Signaling Technology), inhibitor of κBα (IκBα) (9242, Cell Signaling Technology), 
microtubule-associated protein 1 light chain 3 (LC3) (2775, Cell Signaling Technology), 
muscle RING finger 1 (MuRF1) (GTX110475, Gene Tex, Darmstadt, Irvine, CA), 
puromycin (MABE343, Merck Millipore, Darmstadt, Germany), p62 (5114, Cell 
Signaling Technology), 70-kDa ribosomal S6 kinase (p70S6K) Thr389 (9234, Cell 
Signaling Technology), p70S6K (2708, Cell Signaling Technology), ubiquitin (3933, Cell 
Signaling Technology), Unc-51-like kinase 1 (Ulk1) (8054, Cell Signaling Technology), 
β-actin (4967, Cell Signaling Technology)] diluted in Tris buffered saline with 0.1% 
Tween 20 (TBS-T). The membranes were then washed with TBS-T and reacted with anti-
rabbit IgG (7074, Cell Signaling Technology), or anti-mouse IgG2a (ab97245, Abcam, 
Cambridge, UK) for 1h at room temperature. After the final wash with TBS-T, protein 
bands were visualized using chemiluminescence (Wako Pure Chemical Industries, Osaka, 
Japan), and measured using Light-Capture (AE-6971, ATTO Corporation, Tokyo, Japan). 
The intensity of the signals was quantified using ImageJ software (National Institutes of 
Health, MD). The level of β-actin was evaluated as an internal control. 
 
Real-time RT-PCR analyses 
Real-time RT-PCR analyses were performed as was described previously (81). 
Briefly, total RNA was extracted from the soleus muscles (>1 mg) using the miRNeasy 
Mini kit (Qiagen, Hiden, Germany) according to the manufacturer’s protocol. Total RNA 
contents in the extractions were >300 ng in each muscle. For the detection of mRNA, the 
RNA (200 ng) was reverse-transcribed to cDNA using PrimeScript RT Master Mix 
(Takara Bio), and then synthesized cDNA (4 ng) was applied to real-time RT-PCR 
(Thermal Cycler Dice Real Time System IIMRQ, Takara Bio) using Takara SYBR Premix 
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Ex Taq II (Takara Bio). For the detection of microRNA (miRNA or miR), the RNA (60 
ng) was reverse-transcribed to cDNA using Mir-XTM miRNA First Strand Synthesis Kit 
(Clontech Laboratories, Mountain View, CA), and then synthesized cDNA (4 ng) was 
applied to real-time RT-PCR using Mir-XTM miRNA qRT-PCR SYBR Kit (Clontech 
Laboratories). Relative fold change of expression was calculated by the comparative CT 
method with Takara Thermal Cycler Dice Real Time System Software Ver. 4.00. To 
normalize the amount of total RNA present in each reaction, S18 ribosomal RNA (18S 
rRNA) for mRNA, and U6 for miRNAs were used as an internal standard. 
Following primers were used: MuRF1, 5’-AGGACTCCTGCAGAGTGACCAA-3’ 
(forward) and 5’-TTCTCGTCCAGGATGGCGTA-3’ (reverse); atrogin-1/muscle 
atrophy F-box (MAFbx), 5’-TGTCCTTGAATTCAGCAAGCAAAC-3’ (forward) and 
5’-TGTGGCCATCCATTATTTCCAG-3’ (reverse); 18S rRNA, 3’-
ACTCAACACGGGAAACCTCA-5’ (forward) and 3’-
AACCAGACAAATCGCTCCAC-5’ (reverse); miR-1, 5’-
TGGAATGTAAAGAAGTATGTAT-3’ (forward); miR-23a, 5’-
ATCACATTGCCAGGGATTTCC-3’ (forward); miR-133a, 5’-
TTTGGTCCCCTTCAACCAGCTG-3’ (forward); miR-206, 5’-
TGGAATGTAAGGAAGTGTGTGG-3’ (forward); miR-208b, 5’-
ATAAGACGAACAAAAGGTTTGT-3’ (forward); miR-499, 5’-
TTAAGACTTGCAGTGATGTTT-3’ (forward). The U6 primer and reverse primers for 
miRNA were provided with the kit. 
 
Isoform-specific AMPK activity assay 
The AMPK activity assay was performed with some modification of the previously 
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reported method (74). Muscles were homogenized as described in Western blot analyses, 
and resultant supernatants (50 µg of protein) were immunoprecipitated with isoform-
specific antibodies directed against the α1 or α2 catalytic subunits of AMPK (kindly 
gifted by Dr. Licht Miyamoto) and protein A-Sepharose beads (GE Healthcare, 
Buckinghamshire, UK). Immunoprecipitates were washed twice both in wash buffer (240 
mM HEPES and 480 mM NaCl). Kinase reactions were performed in the presence of 
synthesized and purified SAMS peptide (HMRSAMSGLHLVKRR) as AMPK substrate 
(74), and 40 mM HEPES (pH 7.0), 0.2 mM AMP, 80 mM NaCl, 0.8 mM dithiothreitol, 5 
mM MgCl2, 0.2 mM ATP (10 µCi of [γ-32P] ATP/sample) (PerkinElmer, Wellesley, MA) 
in a final volume of 40 µl for 20 min at 30°C. At the end of the reaction, a 15-µL aliquot 
was removed and spotted onto Whatman P81 paper (Whatman International, Maidstone, 
UK). The papers were washed 6 times in 1% phosphoric acid and once in acetone. 32P 
incorporation was quantitated with a scintillation counter, and kinase activity was 
expressed as fold increases relative to the basal samples. 
 
Fiber CSA analyses 
To measure the CSA of individual fibers, muscle cryostat sections were stained for 
laminin, a major component of the basal lamina, by the standard immunohistochemical 
technique (33). Briefly, serial transverse cryosections (7 μm thick) of the frozen samples 
were cut at –20°C and mounted on the slide glasses. Cross sections were fixed with 
paraformaldehyde (4%), and then were post-fixed in ice-cold methanol. After blocking 
by using a reagent (1% Roche Blocking Regent; Roche Diagonost, Penzberg, Germany), 
samples were incubated with the primary antibodies for rabbit polyclonal anti-laminin 
(Z0097, Dako Cytomation, Glostrup, Denmark). Sections were also incubated with the 
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second primary antibodies for fluorescein isothiocyanate-conjugated anti-rabbit IgG. 
Fiber CSA (~100 fibers/muscle) was automatically measured as the internal laminin-
unstained area by using ImageJ. The relative fiber CSA to body size was normalized by 
body weight2/3 according to Jaric et al. (30). 
 
Plasma corticosterone measurement 
Blood samples were collected from carotid artery into tubes containing heparin as 
anticoagulant, and plasma was separated by centrifugation at 8000 g for 15 minutes and 
kept at -80°C until use. Plasma level of corticosterone was measured using ELISA kit 
(Assaypro, St. Charles, MO). 
 
Statistical analyses 
Values were expressed as mean ± SEM. In Figure 3A, values are expressed as mean 
± SD due to small numbers of animals. Statistical significance was analyzed by using 
two-way analysis of variance (ANOVA) with mice and treatments as main factors. If there 
are any significant main effects (mice and/or treatments), post-hoc multiple comparisons 
tests were performed between the factors (WT vs. AMPK-DN and/or untreated control 
vs. hindlimb unloading), and if there are any significant interactions (mice × treatments), 
post-hoc simple effects tests were performed among 4 groups. Post hoc analyses were 
conducted with Tukey-Kramer’s test. Student’s t-test was used to compare the percentage 
decrease by hindlimb unloading in muscle weight between WT and AMPK-DN (Figure 
2C and 2E). The differences between groups were considered statistically significant at P 
< 0.05. The effect size (ES) was also calculated to examine whether the effect was 
meaningful and practically important. We interpreted the magnitude of the ES by using 
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conventional threshold values of 0.1 as the smallest effect, 0.3 as a moderate effect, and 






The measurement results of AMPK activity and phosphorylation level of ACC Ser79, 
a marker of AMPK activity, in soleus muscle are shown in Figure 1. Basal activity of 
AMPKα1 and AMPKα2 was lower by 20% (p<0.05, ES=0.66) and 95% (p<0.05, 
ES=0.97) in AMPK-DN mice than WT mice, respectively (Figure 1A). The predominant 
reduction of AMPKα2 activity rather than AMPKα1 activity in the transgenic mice 
expressing inactive α1 mutant was corresponding with the results previously reported (15, 
32, 44, 70). Hindlimb unloading did not affect both AMPKα1 (p=0.06, ES=0.32) and 
AMPKα2 (p=0.96, ES=0.01) activity (Figure 1A). Basal expression level of 
phosphorylated ACC Ser79 was lower by 55% in AMPK-DN mice than WT mice (p<0.05, 
ES=0.73), and was not affected by hindlimb unloading (p=0.11, ES=0.19, Figure 1B). 
ACC expression was increased by hindlimb unloading (p<0.05, ES=0.37, Figure 1B). 
 
Plasma corticosterone level 
The changes in the plasma corticosterone level, an indicator of stress status, are 
shown in Table 1. The plasma corticosterone level was increased in response to hindlimb 
unloading (p<0.05, ES=0.45), but there was no difference in the levels of corticosterone 
between WT and AMPK-DN mice (p=0.26, ES=0.20, Table 1). 
 
Body weight and muscle mass 
The data of body weight and muscle mass are shown in Figure 2. The overall 
differences in the body weight between mice were statistically significant: the body 
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weight of AMPK-DN mice was slightly less compared to WT mice during experimental 
period (p<0.05, ES=0.23, Figure 2A). The body weight was reduced by hindlimb 
unloading (p<0.05, ES=0.66, Figure 2A).  
Although the absolute soleus weight was reduced by hindlimb unloading (p<0.05, 
ES=0.93), the level after hindlimb unloading in AMPK-DN mice was significantly higher 
than in WT mice (p<0.05, ES=0.29, Figure 2B). The relative soleus weight to body weight 
was also decreased by hindlimb unloading (p<0.05, ES=0.77), and the level after 
hindlimb unloading in AMPK-DN mice was significantly higher than in WT mice 
(p<0.05, ES=0.62, Figure 2C). The degree of % changes were larger in WT mice (30%) 
than in AMPK-DN mice (17%) (p<0.05, ES=0.62, Figure 2C). Similarly, the fiber CSA 
of soleus muscle after hindlimb unloading was smaller than before (p<0.05, ES=0.89, 
Figure 2D). The relative fiber CSA of soleus muscle to body weight2/3 was decreased in 
response to hindlimb unloading (p<0.05, ES=0.76), and the level after hindlimb 
unloading in AMPK-DN mice was significantly higher than in WT mice (p<0.05, 
ES=0.63, Figure 2E). The degree of % changes were larger in WT mice (28%) than in 
AMPK-DN mice (16%) (p<0.05, ES=0.63, Figure 2E). 
The absolute EDL weight was reduced in response to hindlimb unloading (p<0.05, 
ES=0.49), and was lower in AMPK-DN mice compared to WT mice (p<0.05, ES=0.73, 
Figure 2F). The relative EDL weight to body weight was lower in AMPK-DN mice than 
in WT mice (p<0.05, ES=0.56), and no change was observed by hindlimb unloading 
(p=0.07, ES=0.27, Figure 2G). Hindlimb unloading also decreased the absolute GAS-
PLA complex weight (p<0.05, ES=0.77) and the relative GAS-PLA complex weight to 
body weight (p<0.05, ES=0.56, Figure 2H). Both the absolute (p<0.05, ES=0.53) and 
relative (p<0.05, ES=0.52) GAS-PLA complex weight were lower in AMPK-DN mice 
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compared to WT mice (Figure 2I). 
 
Protein synthesis pathway 
Figure 3 shows the changes in the expression of puromycin-labled proteins and 
molecules associated with protein synthesis in soleus muscle. The expression of 
puromycin-labled proteins was diminished by hindlimb unloading (p<0.05, ES=0.61, 
Figure 3A). Correspondingly, the expressions of phosphorylated Akt Ser473 (p<0.05, 
ES=0.57, Figure 3C) and phosphorylated p70S6K Thr389 (p<0.05, ES=0.37, Figure 3D) 
were also decreased in response to hindlimb unloading in both mice. There were no 
differences in these parameters between WT and AMPK-DN mice (Akt: p=0.77, 
ES=0.04; p70S6K: p=0.63, ES=0.11, Figure 3C and 3D). Akt (p<0.05, ES=0.65, Figure 




The changes in the expression of proteins related to autophagy system in soleus 
muscle are shown in Figure 4. Ulk1 expression was increased by hindlimb unloading in 
WT mice (p<0.05, ES=0.63), whereas it was not altered in AMPK-DN mice (p=0.90, 
ES=0.03, Figure 4B). The expression level of LC3I in AMPK-DN mice was same as that 
in WT mice (p=0.41, ES=0.15), and was not altered during hindlimb unloading (p=0.17, 
ES=0.25, Figure 4C). LC3II expression was up-regulated in WT mice (p<0.05, ES=0.50) 
by hindlimb unloading but not in AMPK-DN mice (p=0.25, ES=0.88, Figure 4C). The 
relative expression of LC3II to LC3I was increased in response to hindlimb unloading by 
8.0-fold in WT mice (p<0.05, ES=0.58) but by 2.0-fold in AMPK-DN mice (p=0.19, 
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ES=0.50, Figure 4C). p62 expression was increased by hindlimb unloading in WT mice 
(p<0.05, ES=0.71), but not in AMPK-DN mice (p=0.59, ES=0.12, Figure 4D). 
 
Ubiquitin-proteasome system 
The variations in the expression of ubiquitinated protein and molecules related to 
ubiquitin-proteasome system in soleus muscle are shown in Figure 5. The accumulation 
of ubiquitinated proteins was observed after hindlimb unloading in WT mice (p<0.05, 
ES=0.65), but not in AMPK-DN mice (p=0.77, ES=0.07, Figure 5A). MuRF1 mRNA 
expression was significantly increased in response to hindlimb unloading by 4.0-fold in 
WT mice (p<0.05, ES=0.77), but not in AMPK-DN mice (p=0.28, ES=0.32, Figure 5B). 
The atrogin-1/MAFbx mRNA expression was up-regulated in response to hindlimb 
unloading (p<0.05, ES=0.26, Figure 5B). The protein expression of MuRF1 was also 
higher after hindlimb unloading in WT mice (p<0.05, ES=0.46), whereas there was no 
alteration in AMPK-DN mice (p=0.85, ES=0.06, Figure 5C). 
 
Signaling molecules associated with protein degradation systems 
The changes in the expression of proteins involved in autophagy and ubiquitin-
proteasome systems in soleus muscle are shown in Figure 6. The expression of 
phosphorylated FoxO3a Ser253 was decreased by hindlimb unloading in WT mice (p<0.05, 
ES=0.65), whereas that in AMPK-DN mice was not affected by hindlimb unloading 
(p=0.30, ES=0.14, Figure 6B). The expression of FoxO3a was not different between the 
mice (p=0.46, ES=0.12) and was not changed by hindlimb unloading (p=0.17, ES=0.26, 
Figure 6B). The decrease of the expression level of IκBα by hindlimb unloading was 
observed in WT mice (p=0.07, ES=0.70), whereas there was no alteration in AMPK-DN 
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mice (p=0.85, ES=0.04, Figure 6C). The IκBα expression level after hindlimb unloading 
was higher in AMPK-DN mice than WT mice (p<0.05, ES=0.51, Figure 6C). The 
expression of HSP72 was constantly greater in AMPK-DN mice compared to WT mice 
during experiment (p<0.05, ES=0.57), and was reduced in response to hindlimb 
unloading by half in WT mice and by 20% in AMPK-DN mice (p<0.05, ES=0.35, Figure 
6D). The expression of HSF1 was down-regulated by hindlimb unloading (p<0.05, 
ES=0.52, Figure 6E). 
 
miRNA 
Figure 7 shows the changes in the expression of miRNAs related to skeletal muscle 
atrophy in soleus muscle. The expressions of miR-1 (p<0.05, ES=0.85) and miR-23a 
(p<0.05, ES=0.76) were down-regulated by hindlimb unloading in WT mice while those 
in AMPK-DN mice were not altered (miR-1: p=0.20, ES=0.38; miR-23a: p=0.64, 
ES=0.13, Figure 7A and B). The expressions of miR-133a (p<0.05, ES=0.55, Figure 7C), 
miR-208b (p<0.05, ES=0.64, Figure 7E), and miR-499 (p<0.05, ES=0.69, Figure 7F) 
were reduced in response to hindlimb unloading. There was no effect by hindlimb 





The present study showed that the suppression of skeletal muscle-specific AMPK 
activity, mainly AMPKα2 activity, partially attenuated unloading-induced atrophy of 
slow-twitch soleus muscle, accompanied with suppressed activation of protein 
degradation pathways including ubiquitin-proteasome system. To our knowledge, our 
findings are the first evidence that demonstrates the direct role of AMPK in skeletal 
muscle atrophy in vivo. 
It is well known that diminished loading results in skeletal muscle atrophy (7). The 
hindlimb suspension rodent model was developed to mimic spaceflight-associated 
skeletal muscle atrophy. Furthermore, antigravitational slow soleus muscle has been used 
the most frequently in the experiment of unloading (22, 43, 71, 81) because it is composed 
more than 50% of slow-twitch fiber (78) which is more affected by reduced weight-
bearing. The molecular profiling of soleus muscle in response to hindlimb suspension has 
significance for understanding the underlying mechanism of unloading- and disuse-
associated muscle atrophy. The hindlimb suspension has also proven to be useful for 
investigating the physiological responses to unloading as well as disuse (47), but the 
suspension is some stressful procedure (48). In fact, the high corticosterone levels in 
plasma (Table 1) and the decrease in body weight (Figure 2A) were observed after 
hindlimb unloading, although the changes in plasma corticosterone and body weight in 
both types of mice were identical. 
When the muscle weight was normalized to body weight to correct for the loss of 
weight after hindlimb unloading, the relative weight of soleus (Figure 2C) and GAS-PLA 
(Figure 2I) muscles to body weight were decreased following hindlimb unloading. 
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Notably, soleus muscle was atrophied by ~30% in WT mice during hindlimb unloading, 
while the deficiency of skeletal muscle AMPKα2 activity weakened the progress of 
atrophy almost by half (~17%, Figure 2C and E). In contrast, there was no difference in 
the degree of atrophy in GAS-PLA muscle between WT and AMPK-DN mice. These data 
indicate that AMPK, mainly AMPKα2, may be a crucial molecule regulating unloading-
induced skeletal muscle atrophy, especially in slow-twitch muscle.  
On the other hand, previous study demonstrated that AMPKα1 rather than 
AMPKα2 is important for regulating skeletal muscle mass in overload-induced 
hypertrophy (50). Although we cannot exclude the involvement of AMPKα1 in the 
present study; AMPKα1 activity was also lower by 20% in AMPK-DN mice (Figure 1), 
the different α isoforms might play a major role in regulating skeletal muscle mass under 
hypertrophic or atrophic stimuli. 
A recent study reported that skeletal muscle AMPK signaling was up-regulated at the 
early stage (3 days) of hindlimb unloading and returned to basal state at 7 days in mice  
(11). Correspondingly, our findings showed no activation of AMPK signaling after 2-
week hindlimb unloading (Figure 1). Although we did not examine the time-course 
changes of AMPK activity, it might be that AMPK signaling was temporary activated 
following hindlimb unloading and returned to basal state at 2 weeks in the present study. 
Moreover, it has been reported that soleus muscle atrophy during hindlimb unloading is 
more severe in early (~7 days) phase and moderate in latter (7~14 days) phase (3, 49). 
Therefore, it is speculated that the difference of the progress of soleus muscle atrophy is 
attributed to the suppression of AMPK activation at the early phase of hindlimb unloading. 
Unloading-induced skeletal muscle atrophy is considered to be contributed partly by 
decreased protein synthesis (63). Akt/mammalian target of rapamycin (mTOR)/p70S6K 
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pathway is well established as a central regulator of protein synthesis (45), and the 
negative correlation of AMPK with mTOR signaling has been shown (5). Moreover, in 
vivo researches have demonstrated that AMPK deficiency induces overgrowth in 
overloaded skeletal muscle through up-regulation of mTOR signaling pathway in mice 
(38, 50). In the present study, however, we found that the expression of puromycin-labled 
proteins, an indicator of protein synthesis (20), was down-regulated in response to 
unloading, and this down-regulation was occurred independent of the AMPK activity 
(Figure 3A). Although the down-regulation was statistically significant (p=0.001), there 
was some concern that high variability of the expression in untreated control group of 
WT mice was observed (Figure 3A) and that this experiment was performed with small 
sample size (n=4/group). In regard to this point, we consider that this data is reliable 
because the effect size, a standardized index that is independent of sample size, was large 
(ES=0.61). Moreover, the phosphorylated level of Akt (activated Akt) and p70S6K 
(activated p70S6K) were suppressed by unloading in both mice (Figure 3B and 3C) as 
correspondence with the data of puromycin-labeled proteins. Taken together, it is 
suggested that AMPK-mediated modulation of skeletal muscle mass during unloading is 
controlled by another processes from protein synthesis pathway.  
Interestingly, total Akt expression was increased following hindlimb unloading 
despite decreasing of the phosphorylated form of Akt (Figure 3C). Up-regulation of total 
Akt expression by 3-week hindlimb unloading in mouse muscle was previously reported 
(41). However, it has been shown that total Akt expression was not changed (67) or 
decreased (4) by 2-week hindlimb unloading in rat muscle. Total Akt alterations in 
response to hindlimb unloading have been controversial, and thus further investigation is 
required for this matter. 
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Increased protein degradation is contributed to unloading-induced atrophy in skeletal 
muscle (71). Autophagy is an important cell proteolytic system that controls protein 
turnover in skeletal muscle (42). The process of autophagy is regulated by multiple 
autophagy-related proteins. ULK1, also known as Atg1, is considered to be a key 
serine/threonine protein kinase acting at the early step of autophagosome formation (79). 
During autophagosome formation, LC3I is converted to LC3II through lipidation that 
allows for LC3 to become associated with autophagic vesicles. The presence of LC3 in 
autophagosomes and the conversion of LC3 to the lower migrating form LC3II have been 
used as indicators of autophagy activity (31). Recently, it has been reported that AMPK 
activation stimulates autophagosome formation in skeletal muscle cells (62), thus a 
modulation of autophagy process is possible to involve in AMPK-mediated regulation of 
protein degradation during unloading. In the present study, expression of Ulk1 (Figure 
4B) and relative expression of LC3II to LC3I (Figure 4C) was up-regulated by unloading 
in WT mice, whereas the up-regulation was attenuated in the suppression of AMPK 
activity. These findings indicate that AMPK mediates autophagosome formation during 
unloading-induced skeletal muscle atrophy.  
The ubiquitin-binding protein p62 which binds to LC3 is preferentially degraded by 
autophagy (54), and thus breakdown of p62 is generally used as a marker of autophagy 
flux (46). In the present study, accumulation of p62 after hindlimb unloading was also 
observed in WT mice but not in AMPK-DN mice (Figure 4D). This is consistent with the 
previous findings that p62 mRNA is up-regulated in mouse soleus (10) and gastrocnemius 
(11) muscle following 3-day hindlimb unloading and that p62 protein is increased by 4-
week hindlimb unloading in mouse tibialis anterior and gastrocnemius muscle (40). 
Accumulation of p62 generally indicates an impairment of autophagy flux (46), but p62 
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hyperexpression was also observed in cancer cachexia-induced skeletal muscle atrophy 
despite the autophagy induction (56). In addition, a recent study reported the 
accumulation of p62 in atrophic muscle of aged mice (60). Although our findings indicate 
that AMPK modulates the expression of autophagy-related proteins during unloading-
induced muscle atrophy, we cannot ascertain whether AMPK-mediated autophagy 
regulation is associated with the progress of muscle atrophy in response to hindlimb 
unloading. 
Ubiquitin-proteasome system is also well known as a major protein degradation 
pathway (6). The key enzyme in this pathway is E3 ubiquitin ligases, which is responsible 
for protein ubiquitination. The two muscle-specific ubiquitin ligases, MuRF1 and atrogin-
1/MAFbx, have been considered to be master regulators of skeletal muscle atrophy, 
because these genes are up-regulated in different models of muscle atrophy and have an 
important role in increasing protein degradation through ubiquitin-proteasome system (3, 
19). Previous studies have reported that agonist-induced activation of AMPK enhances 
protein degradation accompanied by increased MuRF1 and atrogin-1/MAFbx mRNA 
expressions in cultured myotubes (35, 52). In addition, we have recently demonstrated 
that pharmacological activation of AMPK up-regulates MuRF1 mRNA expression and 
this up-regulation is abolished in AMPK-knockdown cells (13). Thus, AMPK appears to 
be associated with activation of ubiquitin-proteasome system, and it is possible that 
AMPK regulates protein degradation through ubiquitin-proteasome system during 
unloading. In the present study, the unloading-induced activation of ubiquitin-proteasome 
system, increased expressions of ubiquitinated proteins, MuRF1 mRNA and protein, was 
attenuated in the suppression of AMPK (Figure 5). Therefore, it is suggested that AMPK 
regulates ubiquitin-proteasome system-mediated protein degradation during skeletal 
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muscle atrophy in response to unloading.  
Our findings suggest a role of AMPK that regulates unloading-induced skeletal 
muscle atrophy through modulating protein degradation systems. In this context, there 
are some possible mechanisms by which AMPK activates protein degradation systems 
during unloading. FoxOs are transcriptional factors that regulate transcription of genes 
associated with skeletal muscle homeostasis including skeletal muscle atrophy (61, 65). 
Previous reports have suggested that AMPK-mediated modulation of FoxO3a expression 
and/or nuclear translocation contributes to activation of ubiquitin-proteasome and 
autophagy systems in skeletal muscle cells (52, 62, 73). Thus, it is possible that AMPK 
regulates protein degradation systems in unloaded-associated skeletal muscle atrophy 
through a FoxO3a-dependent mechanism. Phosphorylation of FoxO3a at Ser253 results in 
exclusion from the nucleus and thereby inhibits the transcription activity (8). In the 
present study, the phosphorylation level of FoxO3a at Ser253 was decreased by unloading 
in WT mice (Figure 6B), indicating increased FoxO3a activity. This result is consistent 
with previous reports (25, 65). On the other hand, no change in the expression of 
phosphorylated FoxO3a at Ser253 was observed during unloading in the suppression of 
AMPK activity (Figure 6B), suggesting that AMPK participates in the activation of 
FoxO3a during skeletal muscle unloading. Therefore, FoxO3a is a possible molecule 
related to AMPK-mediated up-regulation of protein degradation systems in response to 
unloading. 
On the other hand, a recent study have suggested that nuclear factor-κB (NF-κB) 
signaling is more important than FoxO signaling in disuse muscle atrophy (80), since NF-
κB sites, but not FoxO sites, are required for the transcription of MuRF1 during hindlimb 
unloading. NF-κB is a transcriptional factor that is sequestered in the cytoplasm by a 
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family of inhibitory proteins called IκBα (51). The IκB kinase complex phosphorylates 
IκBα, resulting in its degradation, thereby leading to nuclear translocation of NFκB and 
activation. It has been reported that disruption of NFκB prevents skeletal muscle atrophy 
induced by hindlimb unloading (29). In the present study, the expression of IκBα tended 
to decrease during muscle atrophy in WT mice, and the expression was high in AMPK-
DN mice compared to WT mice after hindlimb unloading (Figure 6C). These results 
suggest that AMPK regulates NFκB signaling via the expression of IκBα during 
unloading-associated muscle atrophy and this might affect the different activation of 
ubiquitin-proteasome system including MuRF1 expressions. To our knowledge, this is 
the initial report to show the association of AMPK with NFκB signaling in muscle mass 
regulation.  
HSP72 might be another candidate molecule involved in the regulation of AMPK-
mediated protein degradation systems during unloading. HSP72 is one of the most 
prominent member of HSPs family and considered to have an important role in preventing 
skeletal muscle atrophy (64). In the present study, it was observed that HSP72 expression 
in AMPK-DN mice was high and decreased less by unloading compared to WT mice 
(Figure 6D). It has been reported that overexpression of HSP72 in skeletal muscle 
prevents immobilization-induced atrophy in rat (66). Furthermore, a molecular 
mechanism of the resistance to skeletal muscle atrophy by HSP72 seems to be that HSP72 
directly prevents FoxO3a activation during unloading (65, 66). We have also previously 
demonstrated that AMPK negatively regulates HSP72 expression in skeletal muscle cells 
and that HSP72 controls AMPK-mediated activation of ubiquitin-proteasome system (13). 
Considering these findings, it is suggested that a high expression of HSP72 due to the 
suppression of AMPK activity is a possible mechanism that attenuates the unloading-
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induced activation of protein degradation system, partly through FoxO3a deactivation.  
It has been unclear how AMPK regulates HSP72 expression. We obtained the data 
that HSF1, a major transcriptional factor of HSPs in mammalian skeletal muscle (82), 
was down-regulated following hindlimb unloading in both mice (Figure 6E), suggesting 
that AMPK does not modulate HSF1 expression in unloading-induced skeletal muscle 
atrophy. This is supported by the previous data that pharmacological activation of AMPK 
did not affect HSF1 expression in skeletal muscle cells (13). Thus, we consider that 
AMPK-mediated regulation of HSP72 during hindlimb unloading is independent of HSF1.  
It has been provided evidence that a multiple miRNAs are involved in regulation of 
skeletal muscle atrophy (77). We have also shown that AMPK-mediated inhibition of 
skeletal muscle hypertrophy is accompanied by up-regulation of miR-1 (13). Therefore, 
we considered that miRNAs might be potent mediators of AMPK-associated regulation 
of muscle mass during unloading. miRNAs are short and noncoding RNA molecules 
approximately ~20-25 nucleotides in length that suppress gene expressions by binding to 
the 3’-untranslated region of target mRNAs and either inhibit translation or promote 
cleavage of the transcript (1, 24). Recently, it has been shown that miR-23a suppresses 
post-transcriptionally MuRF1 and atrogin-1/MAFbx expression in vitro and that miR-23a 
overexpression in mouse skeletal muscle counteracts dexamethasone-induced muscle 
atrophy (76). Moreover, several reports have suggested that muscle-enriched miRNAs 
(miR-1, miR-133a, miR-206, miR-208b, and miR-499) are associated with modulation 
of skeletal muscle mass. miR-1 and miR-133a are down-regulated by unloading in human 
skeletal muscles (57). miR-1 appears to interact with FoxO3a activity through HSP72 
during dexamethasone-mediated muscle atrophy (36). miR-206 is up-regulated by 
denervation-induced atrophy in mice skeletal muscle, and inhibition of miR-206 partially 
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protects the atrophy (68). miR-208b (9) and miR-499 (2) are potential to repress the 
expression of myostatin, a well-known negative regulator of muscle growth (58). In the 
present study, miR-1 and miR-23a were down-regulated during unloading in WT mice, 
but these responses were not led in the suppression of AMPK activity (Figure 7). Thus, 
these two miRNAs, miR-1 and miR-23a, are potential to involve in the AMPK-mediated 
adaptation of muscle mass and its related molecules during unloading-induced atrophy. 
This is the first study to show the involvement of AMPK with miRNAs during atrophic 
condition, but knowledge about functions of the miRNAs during muscle atrophy is still 
limited and controversial. Our findings would help establish the function of miRNAs in 
regulating skeletal muscle mass. 
In conclusion, we showed that the suppression of muscle-specific AMPK activity 
(mainly AMPKα2) partially attenuated unloading-induced atrophy of slow-twitch soleus 
muscle. The protective effect of muscle atrophy might be attributed to attenuation of the 
activity of ubiquitin-proteasome-mediated protein degradation. This is supported by the 
alterations of signaling molecules including FoxO3a, IκBα, HSP72, and miRNAs (miR-
1 and miR-23a), although there is a limitation that these changes does not reflect dynamics 
of protein degradation directly. Overall, we suggest that AMPK is required for proper 
adaptation of muscle mass and its related molecules during skeletal muscle unloading. 
Further study is expected to clarify the effect of AMPK attenuation on physiological 
parameters such as muscle strength for a better understanding of a role of AMPK in 
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Changes in the plasma corticosterone level by hindlimb unloading. 
  C HU ¶  
corticosterone (ng/ml) 
WT 318.7 ± 44.3 433.1 ± 64.4 
AMPK-DN 355.7 ± 33.0 504.9 ± 58.0 
Values are mean ± SEM; n = 7-8 per group. 
¶: post hoc multiple comparison tests following two-way ANOVA showed that the 
overall differences were statistically significant between untreated control (C) and 
hindlimb unloading (HU) groups. 









Changes in the 5’AMP-activated protein kinase (AMPK) activity in soleus muscle in 
response to hindlimb unloading. (A) isoform-specific AMPK activity. (B) phosphorylated 
acetyl-CoA carboxylase Ser79 (p-ACC) and ACC. Representative immunoblots are shown. 
Values are mean ± SEM. n = 8 per group. †: post hoc multiple comparisons tests following 
two-way ANOVA showed that the overall differences were statistically significant 
between wild-type littermates (WT) mice and mice overexpressed muscle-specific 
AMPK dominant-negative (DN), ¶: post hoc multiple comparisons tests following two-
way ANOVA showed that the overall differences were statistically significant between 
untreated control (C) and hindlimb unloading (HU) groups. 
 
Figure 2 
Changes in the body weight, soleus weight, and muscle fiber cross-sectional area 
(CSA) in response to hindlimb unloading. (A) body weight (BW). (B) soleus weight. (C) 
relative soleus weight to BW. (D) fiber CSA in soleus. (E) relative fiber CSA to BW2/3. 
(F) extensor digitorum longus (EDL) weight. (G) relative EDL weight to BW. (H) 
gastrocnemius-plantaris (GAS-PLA) complex weight. (I) relative GAS-PLA complex 
weight to BW. Representative images of immunofluorescence are shown. Scale bars 
indicate 20 μm. Values are mean ± SEM. n = 6-12 per group. *: post hoc simple effects 
tests following two-way ANOVA or Student’s t test showed that the differences were 
statistically significant between the indicated groups. See Figure 1 for other abbreviations 





Changes in the protein synthesis in response to hindlimb unloading. (A) puromycin-
labled protein. Values are mean ± SD. n = 4 per group. (B) representative immunoblots 
of phosphorylated Akt Ser473 (p-Akt), Akt, phosphorylated 70-kDa ribosomal S6 kinase 
(p70S6K) Thr389 (p-p70S6K) and p70S6K. (C) p-Akt and Akt. Values are mean ± SEM. 
n = 8 per group. (D) p-p70S6K and p70S6K. Values are mean ±SEM. n = 8 per group. 
See Figure 1 for abbreviations and symbols. 
 
Figure 4 
Changes in the autophagy system in response to hindlimb unloading. (A) 
representative immunoblots of Unc-51-like kinase 1 (Ulk1), microtubule-associated 
protein 1 light chain 3 (LC3) and p62. (B) Ulk1. (C) LC3. (D) p62. Values are mean ± 
SEM. n = 8 per group. See Figure 1 and 2 for abbreviations and symbols. 
 
Figure 5 
Changes in the ubiquitin-proteasome system in response to hindlimb unloading. (A) 
ubiquitinated protein. The signal intensity of full-molecular-weight ubiquitinated proteins 
was quantified. (B) mRNA expression of muscle RING finger 1 (MuRF1) and atrogin-
1/muscle atrophy F-box (MAFbx). (C) protein expression of MuRF1. Representative 
immunoblots are shown. Values are mean ± SEM. n = 8 per group. See Figure 1 and 2 for 





Changes in the proteins associated with protein degradation in response to hindlimb 
unloading. (A) representative immunoblots of phosphorylated forkhead box class O 
(FoxO) 3a Ser253 (p-FoxO3a), FoxO3a, inhibitor of κBα (IκBα), 72-kDa heat shock 
protein (HSP72), and heat shock transcription factor 1 (HSF1). (B) p-FoxO3a and 
FoxO3a. (C) IκBα. (D) HSP72. (E) HSF1. Values are mean ± SEM. n = 8 per group. See 
Figure 1 and 2 for abbreviations and symbols. 
 
Figure 7 
Changes in the microRNA (miR) expressions in response to hindlimb unloading. (A) 
miR-1. (B) miR-23a. (C) miR-133a. (D) miR-206. (E) miR-208b. (F) miR-499. Values 
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